Morgan Stanley raises Amgen stock price target on obesity drug potential

Morgan Stanley raises Amgen stock price target on obesity drug potential  Investing.com Canada

Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.